nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—Meniere's disease—Varenicline—nicotine dependence	0.0761	0.0852	CcSEcCtD
Rivastigmine—Restless legs syndrome—Varenicline—nicotine dependence	0.0222	0.0248	CcSEcCtD
Rivastigmine—Tapentadol—OPRM1—nicotine dependence	0.0205	1	CrCbGaD
Rivastigmine—Peripheral ischaemia—Varenicline—nicotine dependence	0.0174	0.0195	CcSEcCtD
Rivastigmine—Varicose vein—Varenicline—nicotine dependence	0.017	0.0191	CcSEcCtD
Rivastigmine—Coronary artery disease—Varenicline—nicotine dependence	0.016	0.018	CcSEcCtD
Rivastigmine—Haematochezia—Varenicline—nicotine dependence	0.0157	0.0176	CcSEcCtD
Rivastigmine—Transient ischaemic attack—Varenicline—nicotine dependence	0.0126	0.0141	CcSEcCtD
Rivastigmine—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.0122	0.0137	CcSEcCtD
Rivastigmine—Balance disorder—Varenicline—nicotine dependence	0.0116	0.013	CcSEcCtD
Rivastigmine—Osteoporosis—Varenicline—nicotine dependence	0.0113	0.0127	CcSEcCtD
Rivastigmine—Suicide attempt—Varenicline—nicotine dependence	0.0112	0.0125	CcSEcCtD
Rivastigmine—Gastric ulcer—Varenicline—nicotine dependence	0.0109	0.0122	CcSEcCtD
Rivastigmine—Libido increased—Varenicline—nicotine dependence	0.0104	0.0117	CcSEcCtD
Rivastigmine—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.00968	0.0108	CcSEcCtD
Rivastigmine—Intestinal obstruction—Varenicline—nicotine dependence	0.0093	0.0104	CcSEcCtD
Rivastigmine—Paranoia—Varenicline—nicotine dependence	0.0093	0.0104	CcSEcCtD
Rivastigmine—Haematemesis—Varenicline—nicotine dependence	0.00913	0.0102	CcSEcCtD
Rivastigmine—Suicidal ideation—Varenicline—nicotine dependence	0.00904	0.0101	CcSEcCtD
Rivastigmine—Thrombosis—Varenicline—nicotine dependence	0.00896	0.01	CcSEcCtD
Rivastigmine—Delusion—Varenicline—nicotine dependence	0.00896	0.01	CcSEcCtD
Rivastigmine—Nystagmus—Varenicline—nicotine dependence	0.00888	0.00994	CcSEcCtD
Rivastigmine—Hyperlipidaemia—Varenicline—nicotine dependence	0.0088	0.00985	CcSEcCtD
Rivastigmine—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00842	0.00943	CcSEcCtD
Rivastigmine—Fungal infection—Varenicline—nicotine dependence	0.00821	0.00919	CcSEcCtD
Rivastigmine—Gingivitis—Varenicline—nicotine dependence	0.00808	0.00905	CcSEcCtD
Rivastigmine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00801	0.0927	CbGpPWpGaD
Rivastigmine—Nephrolithiasis—Varenicline—nicotine dependence	0.00789	0.00883	CcSEcCtD
Rivastigmine—Dysphonia—Varenicline—nicotine dependence	0.00771	0.00863	CcSEcCtD
Rivastigmine—Disturbance in attention—Varenicline—nicotine dependence	0.00732	0.0082	CcSEcCtD
Rivastigmine—Aggression—Varenicline—nicotine dependence	0.00722	0.00808	CcSEcCtD
Rivastigmine—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00702	0.00786	CcSEcCtD
Rivastigmine—Viral infection—Varenicline—nicotine dependence	0.00702	0.00786	CcSEcCtD
Rivastigmine—Nocturia—Varenicline—nicotine dependence	0.00683	0.00765	CcSEcCtD
Rivastigmine—Leukocytosis—Varenicline—nicotine dependence	0.00675	0.00755	CcSEcCtD
Rivastigmine—Dysarthria—Varenicline—nicotine dependence	0.0067	0.00751	CcSEcCtD
Rivastigmine—Coordination abnormal—Varenicline—nicotine dependence	0.00646	0.00723	CcSEcCtD
Rivastigmine—Pulmonary embolism—Varenicline—nicotine dependence	0.00634	0.0071	CcSEcCtD
Rivastigmine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00625	0.0723	CbGpPWpGaD
Rivastigmine—Eructation—Varenicline—nicotine dependence	0.00623	0.00698	CcSEcCtD
Rivastigmine—Influenza like illness—Varenicline—nicotine dependence	0.00616	0.00689	CcSEcCtD
Rivastigmine—Salivary hypersecretion—Varenicline—nicotine dependence	0.00616	0.00689	CcSEcCtD
Rivastigmine—Nightmare—Varenicline—nicotine dependence	0.00612	0.00686	CcSEcCtD
Rivastigmine—Oesophagitis—Varenicline—nicotine dependence	0.00579	0.00649	CcSEcCtD
Rivastigmine—Mouth ulceration—Varenicline—nicotine dependence	0.00573	0.00642	CcSEcCtD
Rivastigmine—Urine output increased—Varenicline—nicotine dependence	0.00573	0.00642	CcSEcCtD
Rivastigmine—Hypertonia—Varenicline—nicotine dependence	0.00556	0.00622	CcSEcCtD
Rivastigmine—Mental disability—Varenicline—nicotine dependence	0.0055	0.00616	CcSEcCtD
Rivastigmine—Lymphadenopathy—Varenicline—nicotine dependence	0.00539	0.00604	CcSEcCtD
Rivastigmine—Sleep disorder—Varenicline—nicotine dependence	0.00532	0.00595	CcSEcCtD
Rivastigmine—Diabetes mellitus—Varenicline—nicotine dependence	0.00529	0.00592	CcSEcCtD
Rivastigmine—Polyuria—Varenicline—nicotine dependence	0.00524	0.00587	CcSEcCtD
Rivastigmine—Deafness—Varenicline—nicotine dependence	0.00514	0.00576	CcSEcCtD
Rivastigmine—Eczema—Varenicline—nicotine dependence	0.00512	0.00573	CcSEcCtD
Rivastigmine—Eye pain—Varenicline—nicotine dependence	0.0051	0.00571	CcSEcCtD
Rivastigmine—Injury—Varenicline—nicotine dependence	0.00501	0.00561	CcSEcCtD
Rivastigmine—Renal failure acute—Varenicline—nicotine dependence	0.00499	0.00558	CcSEcCtD
Rivastigmine—Libido decreased—Varenicline—nicotine dependence	0.00496	0.00556	CcSEcCtD
Rivastigmine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00496	0.0575	CbGpPWpGaD
Rivastigmine—Hot flush—Varenicline—nicotine dependence	0.00492	0.00551	CcSEcCtD
Rivastigmine—Increased appetite—Varenicline—nicotine dependence	0.0049	0.00549	CcSEcCtD
Rivastigmine—Amnesia—Varenicline—nicotine dependence	0.0049	0.00549	CcSEcCtD
Rivastigmine—Menopausal symptoms—Varenicline—nicotine dependence	0.00488	0.00546	CcSEcCtD
Rivastigmine—Atrial fibrillation—Varenicline—nicotine dependence	0.00486	0.00544	CcSEcCtD
Rivastigmine—Thirst—Varenicline—nicotine dependence	0.00484	0.00541	CcSEcCtD
Rivastigmine—Arthritis—Varenicline—nicotine dependence	0.00474	0.0053	CcSEcCtD
Rivastigmine—Hypoglycaemia—Varenicline—nicotine dependence	0.00472	0.00528	CcSEcCtD
Rivastigmine—Cerebrovascular accident—Varenicline—nicotine dependence	0.0047	0.00526	CcSEcCtD
Rivastigmine—Osteoarthritis—Varenicline—nicotine dependence	0.0046	0.00515	CcSEcCtD
Rivastigmine—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.0046	0.00515	CcSEcCtD
Rivastigmine—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00457	0.00511	CcSEcCtD
Rivastigmine—Migraine—Varenicline—nicotine dependence	0.00453	0.00507	CcSEcCtD
Rivastigmine—Affect lability—Varenicline—nicotine dependence	0.00453	0.00507	CcSEcCtD
Rivastigmine—Psychotic disorder—Varenicline—nicotine dependence	0.0045	0.00503	CcSEcCtD
Rivastigmine—Urinary retention—Varenicline—nicotine dependence	0.00438	0.0049	CcSEcCtD
Rivastigmine—Mood swings—Varenicline—nicotine dependence	0.00436	0.00488	CcSEcCtD
Rivastigmine—Liver function test abnormal—Varenicline—nicotine dependence	0.00425	0.00476	CcSEcCtD
Rivastigmine—Dry skin—Varenicline—nicotine dependence	0.00422	0.00472	CcSEcCtD
Rivastigmine—Abdominal pain upper—Varenicline—nicotine dependence	0.0042	0.00471	CcSEcCtD
Rivastigmine—Hypokalaemia—Varenicline—nicotine dependence	0.00419	0.00469	CcSEcCtD
Rivastigmine—Breast disorder—Varenicline—nicotine dependence	0.00416	0.00466	CcSEcCtD
Rivastigmine—Cramp muscle—Varenicline—nicotine dependence	0.00414	0.00464	CcSEcCtD
Rivastigmine—Nasopharyngitis—Varenicline—nicotine dependence	0.00412	0.00461	CcSEcCtD
Rivastigmine—Gastritis—Varenicline—nicotine dependence	0.00407	0.00456	CcSEcCtD
Rivastigmine—Dysphagia—Varenicline—nicotine dependence	0.00398	0.00445	CcSEcCtD
Rivastigmine—Angina pectoris—Varenicline—nicotine dependence	0.00387	0.00434	CcSEcCtD
Rivastigmine—Bronchitis—Varenicline—nicotine dependence	0.00383	0.00428	CcSEcCtD
Rivastigmine—Pollakiuria—Varenicline—nicotine dependence	0.00367	0.00411	CcSEcCtD
Rivastigmine—Erectile dysfunction—Varenicline—nicotine dependence	0.00366	0.0041	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Varenicline—nicotine dependence	0.00363	0.00407	CcSEcCtD
Rivastigmine—Weight increased—Varenicline—nicotine dependence	0.00362	0.00405	CcSEcCtD
Rivastigmine—Hyperglycaemia—Varenicline—nicotine dependence	0.00359	0.00402	CcSEcCtD
Rivastigmine—Infestation NOS—Varenicline—nicotine dependence	0.00355	0.00397	CcSEcCtD
Rivastigmine—Infestation—Varenicline—nicotine dependence	0.00355	0.00397	CcSEcCtD
Rivastigmine—Depression—Varenicline—nicotine dependence	0.00354	0.00396	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00352	0.00394	CcSEcCtD
Rivastigmine—Acute coronary syndrome—Varenicline—nicotine dependence	0.0035	0.00391	CcSEcCtD
Rivastigmine—Myocardial infarction—Varenicline—nicotine dependence	0.00348	0.00389	CcSEcCtD
Rivastigmine—Conjunctivitis—Varenicline—nicotine dependence	0.00345	0.00386	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Varenicline—nicotine dependence	0.00335	0.00376	CcSEcCtD
Rivastigmine—Epistaxis—Varenicline—nicotine dependence	0.00335	0.00375	CcSEcCtD
Rivastigmine—Sinusitis—Varenicline—nicotine dependence	0.00333	0.00373	CcSEcCtD
Rivastigmine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00324	0.0376	CbGpPWpGaD
Rivastigmine—Bradycardia—Varenicline—nicotine dependence	0.00324	0.00363	CcSEcCtD
Rivastigmine—Hallucination—Varenicline—nicotine dependence	0.00317	0.00355	CcSEcCtD
Rivastigmine—Hypoaesthesia—Varenicline—nicotine dependence	0.00317	0.00355	CcSEcCtD
Rivastigmine—Urinary tract disorder—Varenicline—nicotine dependence	0.00314	0.00352	CcSEcCtD
Rivastigmine—Oedema peripheral—Varenicline—nicotine dependence	0.00314	0.00351	CcSEcCtD
Rivastigmine—Connective tissue disorder—Varenicline—nicotine dependence	0.00313	0.0035	CcSEcCtD
Rivastigmine—Urethral disorder—Varenicline—nicotine dependence	0.00312	0.00349	CcSEcCtD
Rivastigmine—Visual impairment—Varenicline—nicotine dependence	0.00307	0.00344	CcSEcCtD
Rivastigmine—Erythema multiforme—Varenicline—nicotine dependence	0.00301	0.00337	CcSEcCtD
Rivastigmine—Eye disorder—Varenicline—nicotine dependence	0.00298	0.00333	CcSEcCtD
Rivastigmine—Tinnitus—Varenicline—nicotine dependence	0.00297	0.00332	CcSEcCtD
Rivastigmine—Cardiac disorder—Varenicline—nicotine dependence	0.00296	0.00331	CcSEcCtD
Rivastigmine—Angiopathy—Varenicline—nicotine dependence	0.00289	0.00323	CcSEcCtD
Rivastigmine—Mediastinal disorder—Varenicline—nicotine dependence	0.00287	0.00321	CcSEcCtD
Rivastigmine—Chills—Varenicline—nicotine dependence	0.00286	0.0032	CcSEcCtD
Rivastigmine—Arrhythmia—Varenicline—nicotine dependence	0.00284	0.00318	CcSEcCtD
Rivastigmine—ACHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0028	0.0324	CbGpPWpGaD
Rivastigmine—Mental disorder—Varenicline—nicotine dependence	0.00279	0.00312	CcSEcCtD
Rivastigmine—Malnutrition—Varenicline—nicotine dependence	0.00277	0.0031	CcSEcCtD
Rivastigmine—Erythema—Varenicline—nicotine dependence	0.00277	0.0031	CcSEcCtD
Rivastigmine—Flatulence—Varenicline—nicotine dependence	0.00273	0.00306	CcSEcCtD
Rivastigmine—Dysgeusia—Varenicline—nicotine dependence	0.00271	0.00304	CcSEcCtD
Rivastigmine—Back pain—Varenicline—nicotine dependence	0.00268	0.003	CcSEcCtD
Rivastigmine—Muscle spasms—Varenicline—nicotine dependence	0.00266	0.00298	CcSEcCtD
Rivastigmine—ACHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00265	0.0307	CbGpPWpGaD
Rivastigmine—Vision blurred—Varenicline—nicotine dependence	0.00261	0.00292	CcSEcCtD
Rivastigmine—Tremor—Varenicline—nicotine dependence	0.0026	0.00291	CcSEcCtD
Rivastigmine—Ill-defined disorder—Varenicline—nicotine dependence	0.00257	0.00288	CcSEcCtD
Rivastigmine—Anaemia—Varenicline—nicotine dependence	0.00256	0.00287	CcSEcCtD
Rivastigmine—Agitation—Varenicline—nicotine dependence	0.00255	0.00285	CcSEcCtD
Rivastigmine—Malaise—Varenicline—nicotine dependence	0.0025	0.0028	CcSEcCtD
Rivastigmine—BCHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0025	0.0289	CbGpPWpGaD
Rivastigmine—Vertigo—Varenicline—nicotine dependence	0.00249	0.00279	CcSEcCtD
Rivastigmine—Syncope—Varenicline—nicotine dependence	0.00249	0.00278	CcSEcCtD
Rivastigmine—Palpitations—Varenicline—nicotine dependence	0.00245	0.00274	CcSEcCtD
Rivastigmine—Loss of consciousness—Varenicline—nicotine dependence	0.00244	0.00273	CcSEcCtD
Rivastigmine—Cough—Varenicline—nicotine dependence	0.00242	0.00271	CcSEcCtD
Rivastigmine—Convulsion—Varenicline—nicotine dependence	0.0024	0.00269	CcSEcCtD
Rivastigmine—Hypertension—Varenicline—nicotine dependence	0.00239	0.00268	CcSEcCtD
Rivastigmine—BCHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00237	0.0274	CbGpPWpGaD
Rivastigmine—Myalgia—Varenicline—nicotine dependence	0.00236	0.00264	CcSEcCtD
Rivastigmine—Chest pain—Varenicline—nicotine dependence	0.00236	0.00264	CcSEcCtD
Rivastigmine—Arthralgia—Varenicline—nicotine dependence	0.00236	0.00264	CcSEcCtD
Rivastigmine—Anxiety—Varenicline—nicotine dependence	0.00235	0.00263	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00234	0.00262	CcSEcCtD
Rivastigmine—Discomfort—Varenicline—nicotine dependence	0.00233	0.00261	CcSEcCtD
Rivastigmine—Dry mouth—Varenicline—nicotine dependence	0.00231	0.00258	CcSEcCtD
Rivastigmine—Oedema—Varenicline—nicotine dependence	0.00226	0.00253	CcSEcCtD
Rivastigmine—Infection—Varenicline—nicotine dependence	0.00225	0.00252	CcSEcCtD
Rivastigmine—Shock—Varenicline—nicotine dependence	0.00223	0.00249	CcSEcCtD
Rivastigmine—Nervous system disorder—Varenicline—nicotine dependence	0.00222	0.00248	CcSEcCtD
Rivastigmine—Thrombocytopenia—Varenicline—nicotine dependence	0.00221	0.00248	CcSEcCtD
Rivastigmine—Tachycardia—Varenicline—nicotine dependence	0.00221	0.00247	CcSEcCtD
Rivastigmine—Skin disorder—Varenicline—nicotine dependence	0.0022	0.00246	CcSEcCtD
Rivastigmine—Hyperhidrosis—Varenicline—nicotine dependence	0.00219	0.00245	CcSEcCtD
Rivastigmine—Anorexia—Varenicline—nicotine dependence	0.00216	0.00241	CcSEcCtD
Rivastigmine—ACHE—Neuronal System—CHRNB3—nicotine dependence	0.00214	0.0248	CbGpPWpGaD
Rivastigmine—Hypotension—Varenicline—nicotine dependence	0.00211	0.00237	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00206	0.00231	CcSEcCtD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00206	0.0239	CbGpPWpGaD
Rivastigmine—Insomnia—Varenicline—nicotine dependence	0.00205	0.00229	CcSEcCtD
Rivastigmine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00203	0.0235	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—CHRNA6—nicotine dependence	0.00203	0.0235	CbGpPWpGaD
Rivastigmine—Dyspnoea—Varenicline—nicotine dependence	0.00202	0.00226	CcSEcCtD
Rivastigmine—Somnolence—Varenicline—nicotine dependence	0.00201	0.00225	CcSEcCtD
Rivastigmine—Dyspepsia—Varenicline—nicotine dependence	0.00199	0.00223	CcSEcCtD
Rivastigmine—Decreased appetite—Varenicline—nicotine dependence	0.00197	0.0022	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00195	0.00219	CcSEcCtD
Rivastigmine—Fatigue—Varenicline—nicotine dependence	0.00195	0.00218	CcSEcCtD
Rivastigmine—Pain—Varenicline—nicotine dependence	0.00193	0.00217	CcSEcCtD
Rivastigmine—Constipation—Varenicline—nicotine dependence	0.00193	0.00217	CcSEcCtD
Rivastigmine—ACHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00192	0.0222	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—CHRNB3—nicotine dependence	0.00191	0.0221	CbGpPWpGaD
Rivastigmine—Feeling abnormal—Varenicline—nicotine dependence	0.00186	0.00209	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00185	0.00207	CcSEcCtD
Rivastigmine—ACHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00184	0.0213	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—CHRNA6—nicotine dependence	0.00181	0.021	CbGpPWpGaD
Rivastigmine—Urticaria—Varenicline—nicotine dependence	0.0018	0.00201	CcSEcCtD
Rivastigmine—Body temperature increased—Varenicline—nicotine dependence	0.00179	0.002	CcSEcCtD
Rivastigmine—Abdominal pain—Varenicline—nicotine dependence	0.00179	0.002	CcSEcCtD
Rivastigmine—BCHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00171	0.0198	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00171	0.0198	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00167	0.0193	CbGpPWpGaD
Rivastigmine—Hypersensitivity—Varenicline—nicotine dependence	0.00167	0.00187	CcSEcCtD
Rivastigmine—BCHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00164	0.019	CbGpPWpGaD
Rivastigmine—Asthenia—Varenicline—nicotine dependence	0.00162	0.00182	CcSEcCtD
Rivastigmine—Pruritus—Varenicline—nicotine dependence	0.0016	0.00179	CcSEcCtD
Rivastigmine—Diarrhoea—Varenicline—nicotine dependence	0.00155	0.00173	CcSEcCtD
Rivastigmine—BCHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00152	0.0177	CbGpPWpGaD
Rivastigmine—Dizziness—Varenicline—nicotine dependence	0.0015	0.00167	CcSEcCtD
Rivastigmine—ACHE—Neuronal System—GABRA4—nicotine dependence	0.00147	0.017	CbGpPWpGaD
Rivastigmine—Vomiting—Varenicline—nicotine dependence	0.00144	0.00161	CcSEcCtD
Rivastigmine—Rash—Varenicline—nicotine dependence	0.00143	0.0016	CcSEcCtD
Rivastigmine—Dermatitis—Varenicline—nicotine dependence	0.00142	0.0016	CcSEcCtD
Rivastigmine—Headache—Varenicline—nicotine dependence	0.00142	0.00159	CcSEcCtD
Rivastigmine—ACHE—Neuronal System—CHRNB4—nicotine dependence	0.00141	0.0163	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00139	0.0161	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00135	0.0156	CbGpPWpGaD
Rivastigmine—Nausea—Varenicline—nicotine dependence	0.00134	0.0015	CcSEcCtD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00133	0.0154	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—GABRA4—nicotine dependence	0.00131	0.0152	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—CHRNA5—nicotine dependence	0.00131	0.0152	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—CHRNB4—nicotine dependence	0.00126	0.0145	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00124	0.0144	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00123	0.0142	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—CHRNA5—nicotine dependence	0.00117	0.0135	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00111	0.0129	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00109	0.0127	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00109	0.0126	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—CHRNA3—nicotine dependence	0.00107	0.0124	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000994	0.0115	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—CHRNA3—nicotine dependence	0.000952	0.011	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000941	0.0109	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—CHRNB2—nicotine dependence	0.00094	0.0109	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000887	0.0103	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000875	0.0101	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—CHRNA4—nicotine dependence	0.000853	0.00988	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—CHRNB2—nicotine dependence	0.000838	0.00971	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—CHRNA4—nicotine dependence	0.000761	0.00881	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000615	0.00713	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00058	0.00672	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000572	0.00662	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP2A7—nicotine dependence	0.00037	0.00428	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP2A7—nicotine dependence	0.00033	0.00382	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000152	0.00176	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	9.92e-05	0.00115	CbGpPWpGaD
